Beta-blocker Therapy at Discharge in Patients with Acute Heart Failure and Atrial Fibrillation.

Min Soo Ahn Byung-Su Yoo Jung Woo Son Min Heui Yu Dae Ryong Kang Hae-Young Lee Eun Seok Jeon Jae-Joong Kim Shung Chull Chae Sang-Hong Baek Seok-Min Kang Youngkeun Ahn Kye Hun Kim Myeong-Chan Cho Seong Yoon Kim

Published in: Journal of Korean medical science (2020)

In the HFrEF with AF PS-matched cohort, the use of BBs at discharge was not associated with clinical outcome. However, in HFpEF with AF, the use of BB was associated with reduced rehospitalization during the 6-month and 1-year follow up.

Keyphrases

atrial fibrillation
acute heart failure
heart failure
oral anticoagulants
catheter ablation
left atrial
left atrial appendage
direct oral anticoagulants
growth factor
percutaneous coronary intervention
angiotensin converting enzyme
coronary artery disease
bone marrow
acute coronary syndrome
smoking cessation